The articles shown below — all from open-access medical journals — are provided as examples of the wide range of recently published OM-related information and research findings. ("Open-access" journals enable public access of their articles at no cost when they are published.) Each of these free journal articles has been linked to its PDF version for easier readability and printing.
Two main categories of journal articles — Reviews and Original Research — make up the list below. After each article's title, its category is noted for you. If interested:
These free journal articles on ocular melanoma were found through the National Institutes of Health's PubMed database using the pre-set links provided to you on EyeMelanoma.org's "How to Search for Medical Journal Articles" webpage. (The "How to Search" webpage also provides information on defining your own search criteria as well as suggestions for finding free access to the numerous articles in fee-based journals.) Performing your own customized search is strongly encouraged. In the last year alone, more than 500 journal articles about ocular melanoma have been added to PubMed.
The following list of articles has separate sections for uveal melanoma and conjunctival melanoma:
Authors: Im, Peng, Xu, et al. In International Journal of Molecular Sciences, June 2022.
Authors: Gallenga1, Franco, Adamo, et al. In Frontiers in Oncology, April 2022.
Authors: Sundaramurthi, García-Mulero,Tonelotto, et al. In Cancers, February 2022.
Authors: Yang, Tan, Qiao, et al. In Cancer Gene Therapy, February 2022.
Authors: Lamas, Martel, Nahon-Estève, et al. In Cancers, December 2021.
Authors: Seedor, Orloff, and Sato. In Cancers, November 2021.
Authors: Sahoo, Ranjan, Tyagi, et al. In Clinical Ophthalmology, September 2021.
Authors: Romano, Catania, Confalonieri, et al. In International Journal of Molecular Sciences, September 2021.
Authors: Szeligo, Ivey, and Boone. In Cancers, July 2021.
Authors: Bustamante, Tsering, Coblentz, et al. In Journal of Experimental & Clinical Cancer Research, June 2021.
Authors: Hussain, Coupland, Kalirai, et al. In Cancers, May 2021
Authors: Fallico, Raciti, Longo, et al. In International Journal of Oncology, April 2021.
Authors: Marseglia, Amaro, Solari, et al. In Cancers, April 2021.
Authors: Miller, Schoenfield, Abdel-Rahmana, et al. In Ocular Oncology and Pathology, April 2021.
Authors: van Poppelen, de Bruyn, Bicer, et al. In International Journal of Molecular Sciences, January 2021.
Authors: Ortega, Fraile-Martínez, García-Honduvilla, et al. In International Journal of Molecular Sciences, December 2020.
Authors: Rodriguez, Sanchez, Decatur, et al. In Cancers, October 2020.
Authors: Houtzagers, Wierenga, Ruys, et al. In International Journal of Molecular Sciences, September 2020.
Authors: Nardou, Nicolas, Kuttler, et al. In Cancers, March 2022.
Authors: Peil, Bock, Kiefer, et al. In International Journal of Molecular Sciences, January 2022.
Authors: Nahon-Estève, Bertolotto, Picard-Gauci, et al. In Cancers, November 2021.
Authors: Djulbegovic, Uversky, Harbour, et al. In Genes, October 2021.
Authors: Gardrat, Houy, Brooks, et al. In Cancers, July 2021.
Authors: van Poppelen, de Bruyn, Bicer, et al. In International Journal of Molecular Sciences, January 2021. [Note: Also listed above in "uveal melanoma" articles.]
>> "Current Management of Conjunctival Melanoma: Parts 1 and 2"
Authors: Koc and Kiratli. In Turkish Journal of Ophthalmology.
Authors: Gkiala and Palioura. In Clinical Ophthalmology, October 2020.
This not-for-profit website does not contain any advertisements and does not receive funding/donations of any kind.
Information on this site should not be used as a substitute for professional medical care or advice.
Copyright © 2011–2022. EYEMELANOMA.ORG. All Rights Reserved.
EyeMelanoma.org has been providing current information on ocular melanoma since 2011.
This nonprofit website does not contain any advertisements and does not receive funding/donations of any kind.
Google Analytics is used within this site to determine the number of visitors. Data is anonymous.